نتایج جستجو برای: blockers

تعداد نتایج: 20508  

Journal: :Asian journal of research in medical and pharmaceutical sciences 2022

This case report describes the very rarest possibility of drug induced hyperkalemia with beta blockers. In literature search only 2 cases were reported as metoprolol succinate in diabetes patients without renal insufficiency. As per FDA reports 0.5 % have by [1]. Patient is diabetic and hypertensive. And she on oral hypoglycemic agents, premixed insulin blockers along calcium channel blocker. T...

2010
Alain Berdeaux

Both ivabradine (Procoralan), the first I(f) current inhibitor of the cardiac pacemaker cells, and b-blockers reduce heart rate and exhibit potent anti-ischemic effects. Although b-blockers are still the first choice of medication to treat patients suffering from myocardial ischemia, numerous experimental and clinical arguments are now available from which to conclude that ivabradine not only i...

Journal: :Circulation 2011
Ian M Kronish Mark Woodward Ziad Sergie Gbenga Ogedegbe Louise Falzon Devin M Mann

BACKGROUND Observational studies suggest that there are differences in adherence to antihypertensive medications in different classes. Our objective was to quantify the association between antihypertensive drug class and adherence in clinical settings. METHODS AND RESULTS Studies were identified through a systematic search of English-language articles published from the inception of computeri...

Journal: :Rheumatology 2006
M C Kapetanovic T Saxne A Sjöholm L Truedsson G Jönsson P Geborek

OBJECTIVE To compare antibody responses to 23-valent pneumococcal vaccine (Pneumovax) in controls and patients with established rheumatoid arthritis (RA) treated with TNF blockers, methotrexate (MTX) or a combination of both. METHODS Patients with RA (n = 149) and healthy controls (n = 47) were vaccinated. Treatment with TNF blockers (etanercept or infliximab) and MTX was given to 50 patients...

2001
Milan Pavlović

In post myocardial infarction patients beta blockers have shown a reduction of total mortality (23%), sudden cardiac death (25%) and non fatal reinfarction (30%). Beside beta blockers, only a few agents have shown reduction of mortality and sudden cardiac death in post myocardial infarction patients. Beta blockers have showed more favorable effects In patients with Q wave myocardial infarction ...

2013
Gurmukh S Sainani Nihar P Mehta

For more than 3 decades beta blockers have been widely used in the treatment of hypertension and are still recommended as first line agents (1,2). Beta blockers have been in use not only in hypertension but in other cardiovascular conditions. Since long period, beta blockers have assumed a guideline-recommended treatment option for hypertension. However, recent meta-analyses have questioned whe...

2014
Wesley T. O’Neal Jimmy T. Efird Stephen W. Davies Jason B. O’Neal William F. Griffin T. Bruce Ferguson W. Randolph Chitwood Alan P. Kypson

INTRODUCTION The use of discharge β-blockers after cardiac surgery is associated with a long-term mortality benefit. β-Blockers have been suggested to be less effective in black cardiovascular patients compared with whites. To date, racial differences in the long-term survival of coronary artery bypass grafting (CABG) patients who receive β-blockers at discharge have not been examined. METHOD...

Journal: :Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2004
Ritsuko Miyajima Kazumi Sano Hisahiro Yoshida

To clarify contradictions in past reports and the package inserts for beta-adrenergic blocking agents (beta-blockers) for patients with intermittent claudication (IC), we investigated the effects of beta-blockers in patients with IC using the systematic review technique. Data sources were randomized, controlled trials that investigated the effects of beta-blockers compared with the placebo or u...

2017
Sean Duffy Robert Marron Helen Voelker Richard Albert John Connett William Bailey Richard Casaburi J. Allen Cooper Jeffrey L. Curtis Mark Dransfield MeiLan K. Han Barry Make Nathaniel Marchetti Fernando Martinez Stephen Lazarus Dennis Niewoehner Paul D. Scanlon Frank Sciurba Steven Scharf Robert M. Reed George Washko Prescott Woodruff Charlene McEvoy Shawn Aaron Don Sin Gerard J. Criner

BACKGROUND Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective studies have shown that cardio-selective beta-blockers are safe in COPD and possibly beneficial. However, these benefits may reflect symptom impr...

2014
Yoshiyuki Morishita Eiji Kusano Daisuke Nagata

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید